Clinical Trial Update: A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children [Phase 3]

View source ↗

Summary

Long-term safety data from a Phase 3 extension study of sildenafil citrate in children with pulmonary arterial hypertension has been completed, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Sildenafil citrate (Sildenafil citrate)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2014-08-11